"I love Home | splisense.com"

2022-10-01 03:12:59

AboutWho We AreManagement TeamSpliSense Board of DirectorsTechnologyOur PlatformAbout Antisense Oligonucleotides (ASOs)About Cystic FibrosisAbout Muco – Obstructive Lung (Pulmonary) DiseasesPipelineIntroSPL84SPL23SPL16SPL5Additional OpportunitiesNewsPresentationsPress ReleasesPublicationsCareerContact UsMenuAboutWho We AreManagement TeamSpliSense Board of DirectorsTechnologyOur PlatformAbout Antisense Oligonucleotides (ASOs)About Cystic FibrosisAbout Muco – Obstructive Lung (Pulmonary) DiseasesPipelineIntroSPL84SPL23SPL16SPL5Additional OpportunitiesNewsPresentationsPress ReleasesPublicationsCareerContact UsTransformative RNA Based Treatments-Antisense Oligonucleotides-Targeting the Root Cause of Genetic and Pulmonary DiseasesOur innovative RNA based therapies, based on Antisense Oligonucleotides (ASOs), restore and modify protein functionality, addressing untreatable genetic illnesses and pulmonary diseases.TECHNOLOGYPIPELINETransformative RNA-Based TreatmentsSpliSense is a company developing transformative RNA-based treatments for unmet needs relating to diverse pulmonary diseases and Cystic Fibrosis (CF). Our treatment is based on clinically validated Antisense Oligonucleotide (ASO) technology, delivered non-invasively by inhalation to the lungs.We are focused on a variety of innovative therapies, in different development stages from discovery to IND.Learn more >>Learn moreAboutTechnologyPipelineNewsCorp PresentationCareerContact UsMenuAboutTechnologyPipelineNewsCorp PresentationCareerContact UsAboutTechnologyPipelineNewsCorp PresentationCareerContact UsMenuAboutTechnologyPipelineNewsCorp PresentationCareerContact Us+972-52-836-77-31© 2021 All rights Reserved. Design by SCOOPFacebookTwitterYoutubeScroll UpSkip to contentOpen toolbarAccessibility ToolsHigh ContrastNegative ContrastLight BackgroundLinks UnderlineReadable FontReset